SGMT - Sagimet Biosciences Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$29.00
LOW:
$7.00
MEDIAN:
$22.00
CONSENSUS:
$20.00
UPSIDE:
108.77%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||||||
| R&D Expenses | 11.5 | 7.0 | 6.7 | 9.7 | 7.2 | 15.3 | 14.2 | 12.7 | 6.3 | 5.3 | 5.7 | 5.0 | 4.7 | 4.5 | 5.8 | 6.8 | 6.4 | 5.9 |
| SG&A Expenses | 4.3 | 4.7 | 4.0 | 4.6 | 4.7 | 4.5 | 4.0 | 4.2 | 4.3 | 3.5 | 3.8 | 4.5 | 2.4 | 2.3 | 1.5 | 0.8 | 0.9 | 2.9 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 15.8 | 11.7 | 10.8 | 14.3 | 11.9 | 19.9 | 18.2 | 16.9 | 10.6 | 8.8 | 9.5 | 9.5 | 7.1 | 6.8 | 7.4 | 7.7 | 7.2 | 8.7 |
| Operating Income | ||||||||||||||||||
| Operating Income | (15.8) | (11.7) | (10.8) | (14.3) | (11.9) | (19.9) | (18.2) | (16.9) | (10.6) | (8.8) | (9.5) | (7.5) | (7.1) | (6.8) | (7.4) | (7.7) | (7.2) | (8.7) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 1.1 | (3.2) | 1.4 | 1.5 | 1.7 | 2.0 | 2.3 | 2.5 | 2.1 | 1.3 | 1.1 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 |
| Profitability | ||||||||||||||||||
| EBITDA | (14.0) | (10.7) | (12.2) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | 2.1 | 1.3 | (6.4) | (6.8) | (6.6) | 0.2 | 0.2 | (7.1) | (8.7) |
| EBIT | (14.0) | (10.7) | (12.2) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | (6.6) | (8.2) | (6.4) | (6.8) | (6.6) | (7.2) | (7.5) | (7.1) | (8.7) |
| Income Before Tax | (14.0) | (10.7) | (9.6) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | (6.6) | (8.2) | (6.4) | (6.8) | (6.6) | (7.2) | (7.5) | (7.1) | (8.7) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (14.0) | (10.7) | (9.6) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | (6.6) | (8.2) | (6.4) | (6.8) | (6.6) | (7.2) | (7.5) | (7.1) | (8.7) |
| Per Share Data | ||||||||||||||||||
| EPS (Basic) | -0.26 | -0.33 | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.30 | -0.32 | -0.34 | -0.32 | -0.39 |
| EPS (Diluted) | -0.26 | -0.33 | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.30 | -0.32 | -0.34 | -0.32 | -0.39 |
| Shares Outstanding | 53.1 | 32.6 | 32.5 | 32.5 | 32.2 | 32.2 | 32.2 | 32.1 | 31.9 | 29.0 | 18.2 | 18.2 | 22.2 | 22.2 | 22.2 | 22.2 | 22.2 | 22.2 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||||
| Cash & Cash Equivalents | 165.9 | 36.6 | 35.0 | 32.5 | 42.3 | 64.7 | 75.8 | 77.0 | 96.0 | 176.8 | 75.1 | 101.8 | 18.5 | 12.3 | 0.2 |
| Short-Term Investments | 74.2 | 67.9 | 78.1 | 84.2 | 83.1 | 79.9 | 75.4 | 75.5 | 70.4 | 16.9 | 19.8 | 0 | 0 | 12.9 | 32.2 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0.7 | 0.5 | 0.3 | 0.8 | 0.9 | 0.5 | 0.4 | 0.1 | 0.1 | 0.4 | 0.1 | 2.7 | 1.4 | 0.0 |
| Total Current Assets | 244.0 | 107.7 | 116.4 | 119.2 | 127.2 | 146.1 | 152.8 | 157.2 | 166.8 | 194.5 | 96.6 | 102.8 | 21.4 | 27.0 | 32.8 |
| Non-Current Assets | |||||||||||||||
| Property, Plant & Equipment | 2.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 8.8 | 10.1 | 0 | 7.4 | 17.5 | 22.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 17.5 | 0 | 0 | 0.2 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Total Non-Current Assets | 19.4 | 0.0 | 0.1 | 9.2 | 10.2 | 0.1 | 7.5 | 17.6 | 22.3 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Total Assets | 263.4 | 107.8 | 116.5 | 128.4 | 137.4 | 146.2 | 160.3 | 174.8 | 189.0 | 194.5 | 96.7 | 102.9 | 21.5 | 27.3 | 33.0 |
| Current Liabilities | |||||||||||||||
| Account Payables | 1.1 | 2.3 | 1.3 | 4.2 | 1.9 | 3.2 | 1.4 | 1.2 | 2.0 | 0.5 | 0.2 | 1.7 | 2.7 | 1.5 | 1.1 |
| Short-Term Debt | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0.0 | 0.0 | 3.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.6 | 0.1 | 0.1 | 1.0 | 0.1 |
| Total Current Liabilities | 5.4 | 5.3 | 5.1 | 9.1 | 7.2 | 7.2 | 4.5 | 4.1 | 5.7 | 4.5 | 5.7 | 5.0 | 5.3 | 5.3 | 5.3 |
| Non-Current Liabilities | |||||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 214.6 | 0 | 214.6 |
| Total Non-Current Liabilities | 1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 214.6 | 0.0 | 214.7 |
| Total Liabilities | 7.3 | 5.3 | 5.1 | 9.1 | 7.2 | 7.2 | 4.5 | 4.1 | 5.7 | 4.5 | 5.7 | 5.0 | 219.9 | 5.3 | 220.0 |
| Stockholders' Equity | |||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (371.0) | (357.0) | (346.3) | (336.8) | (323.9) | (313.5) | (295.3) | (279.1) | (264.5) | (256.4) | (249.7) | (241.6) | (235.2) | (228.5) | (221.9) |
| Accumulated Other Comprehensive Income | (0.1) | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | (0.0) | 0.0 | 0.0 | 0 | 0 | (0.0) | (0.1) |
| Total Stockholders' Equity | 256.2 | 102.5 | 111.4 | 119.3 | 130.2 | 139.0 | 155.8 | 170.7 | 183.3 | 190.0 | 91.1 | 97.9 | (198.4) | 21.9 | (186.9) |
| Total Liabilities & Equity | 263.4 | 107.8 | 116.5 | 128.4 | 137.4 | 146.2 | 160.3 | 174.8 | 189.0 | 194.5 | 96.7 | 102.9 | 21.5 | 27.3 | 33.0 |
| Debt Metrics | |||||||||||||||
| Total Debt | 1.9 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Net Debt | (164.0) | (36.6) | (34.9) | (32.4) | (42.2) | (64.7) | (75.8) | (76.9) | (95.8) | (176.8) | (75.1) | (101.7) | (18.4) | (12.2) | 0.1 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Net Income | (14.0) | (10.7) | (9.6) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | (6.6) | (8.2) | (6.4) | (6.8) | (6.6) | (7.2) | (7.5) | (7.1) | (8.7) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.8 | 9.5 | 0 | 0 | 0 | 7.4 | 7.7 | 0.0 | 0.0 |
| Stock-Based Compensation | 3.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.5 | 1.5 | 1.5 | 1.4 | 0.8 | 1.3 | 1.9 | 1.1 | 0.8 | 0.7 | 0.4 | 0.4 | 0.4 |
| Change in Working Capital | 0.1 | 0.3 | (4.3) | 0.7 | (0.1) | (0.7) | 3.7 | (0.2) | 1.5 | (0.2) | (0.3) | 0.6 | (0.0) | (1.3) | (0.9) | 0.9 | 0.6 | 3.7 |
| Other Non-Cash Items | (0.5) | (0.1) | 0.3 | 0.3 | (0.2) | 2.9 | (0.0) | (6.3) | (0.4) | (8.9) | (9.4) | 0.0 | 0.0 | 0.0 | (7.4) | (7.7) | (0.0) | (0.0) |
| Operating Cash Flow | (10.7) | (8.6) | (11.8) | (10.2) | (9.1) | (14.5) | (11.0) | (19.6) | (5.6) | (6.2) | (7.1) | (3.9) | (5.7) | (7.1) | (7.5) | (6.2) | (6.1) | (4.7) |
| Investing Activities | ||||||||||||||||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (39.9) | (6.8) | (17.1) | (31.3) | (43.0) | (15.6) | (13.8) | (94.3) | (83.0) | 0 | (19.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 15.9 | 17.0 | 31.4 | 31.3 | 29.7 | 19.0 | 23.6 | 12.0 | 7.8 | 3 | 0 | 0 | 12.8 | 19.4 | 5.4 | 4 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (41.4) | 0 |
| Investing Cash Flow | (24.0) | 10.2 | 14.4 | 0.1 | (13.3) | 3.4 | 9.8 | 0.6 | (75.2) | 3 | (19.6) | 0 | 12.8 | 19.4 | 5.4 | 4 | (41.4) | 0 |
| Financing Activities | ||||||||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 164.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.9) | 0 | 1.1 | (0.9) | (0.1) | (0.1) | 0 | (0.0) | 0 |
| Financing Cash Flow | 339.4 | 0 | 0 | 0.3 | 0.0 | 0 | 0 | 0 | (0.0) | 104.8 | 3.5 | 87.2 | (0.9) | (0.1) | (0.1) | 0 | (0.0) | 0.0 |
| Cash Position | ||||||||||||||||||
| Net Change in Cash | 304.7 | 1.6 | 2.5 | (9.8) | (22.4) | (11.1) | (1.2) | (18.9) | (80.8) | 101.6 | (26.7) | 83.3 | 6.2 | 12.2 | (2.1) | (2.2) | (47.6) | (4.7) |
| Cash at Beginning | 36.6 | 35.0 | 32.5 | 42.3 | 64.7 | 75.8 | 77.0 | 96.0 | 176.8 | 75.1 | 101.8 | 18.5 | 12.3 | 0.2 | 2.2 | 4.5 | 52.1 | 56.7 |
| Cash at End | 341.3 | 36.6 | 35.0 | 32.5 | 42.3 | 64.7 | 75.8 | 77.0 | 96.0 | 176.8 | 75.1 | 101.8 | 18.5 | 12.3 | 0.2 | 2.2 | 4.5 | 52.1 |
| Free Cash Flow | (10.7) | (8.6) | (11.8) | (10.2) | (9.1) | (14.5) | (11.0) | (19.6) | (5.6) | (6.2) | (7.1) | (3.9) | (5.7) | (7.1) | (7.5) | (6.2) | (6.1) | (4.7) |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (15.8) | (11.7) | (10.8) | (14.3) | (11.9) | (19.9) | (18.2) | (16.9) | (10.6) | (8.8) | (9.5) | (7.5) | (7.1) | (6.8) | (7.4) | (7.7) | (7.2) | (8.7) |
| Net Income | (14.0) | (10.7) | (9.6) | (12.9) | (10.4) | (18.2) | (16.2) | (14.6) | (8.1) | (6.6) | (8.2) | (6.4) | (6.8) | (6.6) | (7.2) | (7.5) | (7.1) | (8.7) |
| EPS (Diluted) | -0.26 | -0.33 | -0.29 | -0.40 | -0.32 | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 | -0.45 | -0.35 | -0.31 | -0.30 | -0.32 | -0.34 | -0.32 | -0.39 |
| Balance Sheet | ||||||||||||||||||
| Cash & Equivalents | 165.9 | 36.6 | 35.0 | 32.5 | 42.3 | 64.7 | 75.8 | 77.0 | 96.0 | 176.8 | 75.1 | 101.8 | 18.5 | 12.3 | 0.2 | |||
| Total Assets | 263.4 | 107.8 | 116.5 | 128.4 | 137.4 | 146.2 | 160.3 | 174.8 | 189.0 | 194.5 | 96.7 | 102.9 | 21.5 | 27.3 | 33.0 | |||
| Total Debt | 1.9 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | |||
| Stockholders' Equity | 256.2 | 102.5 | 111.4 | 119.3 | 130.2 | 139.0 | 155.8 | 170.7 | 183.3 | 190.0 | 91.1 | 97.9 | (198.4) | 21.9 | (186.9) | |||
| Cash Flow | ||||||||||||||||||
| Operating Cash Flow | (10.7) | (8.6) | (11.8) | (10.2) | (9.1) | (14.5) | (11.0) | (19.6) | (5.6) | (6.2) | (7.1) | (3.9) | (5.7) | (7.1) | (7.5) | (6.2) | (6.1) | (4.7) |
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | (10.7) | (8.6) | (11.8) | (10.2) | (9.1) | (14.5) | (11.0) | (19.6) | (5.6) | (6.2) | (7.1) | (3.9) | (5.7) | (7.1) | (7.5) | (6.2) | (6.1) | (4.7) |